{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:57:06Z","timestamp":1790236626744,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T00:00:00Z","timestamp":1362787200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00259-013-2375-1","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T07:41:30Z","timestamp":1362728490000},"page":"1095-1101","source":"Crossref","is-referenced-by-count":57,"title":["Utility of 18F-FDG PET(\/CT) in patients with systemic and localized amyloidosis"],"prefix":"10.1007","volume":"40","author":[{"given":"Andor W. J. M.","family":"Glaudemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riemer H. J. A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi A. J. O.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouke P. C.","family":"Hazenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,9]]},"reference":[{"key":"2375_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/13506129.2010.526812","volume":"17","author":"JD Sipe","year":"2010","unstructured":"Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 2010;17:101\u20134.","journal-title":"Amyloid"},{"key":"2375_CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.57.121304.131243","volume":"57","author":"MB Pepys","year":"2006","unstructured":"Pepys MB. Amyloidosis. Annu Rev Med 2006;57:223\u201341.","journal-title":"Annu Rev Med"},{"key":"2375_CR3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/13506129909007308","volume":"6","author":"KE Olsen","year":"1999","unstructured":"Olsen KE, Sletten K, Sandgren O, Olsson H, Myrvold K, Westermark P. What is the role of giant cells in AL-amyloidosis? Amyloid 1999;6:89\u201397.","journal-title":"Amyloid"},{"key":"2375_CR4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/03009734.2012.654861","volume":"117","author":"P Westermark","year":"2012","unstructured":"Westermark P. Localized AL amyloidosis: a suicidal neoplasm? Ups J Med Sci 2012;117:244\u201350.","journal-title":"Ups J Med Sci"},{"key":"2375_CR5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","volume":"337","author":"RH Falk","year":"1997","unstructured":"Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997;337:898\u2013909.","journal-title":"N Engl J Med"},{"key":"2375_CR6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583\u201396.","journal-title":"N Engl J Med"},{"key":"2375_CR7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","volume":"79","author":"MA Gertz","year":"2005","unstructured":"Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005;79:319\u201328.","journal-title":"Am J Hematol"},{"key":"2375_CR8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00041552-200211000-00013","volume":"11","author":"PN Hawkins","year":"2002","unstructured":"Hawkins PN. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 2002;11:649\u201355.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2375_CR9","doi-asserted-by":"crossref","first-page":"355.e15","DOI":"10.1016\/j.amjmed.2005.08.043","volume":"119","author":"BP Hazenberg","year":"2006","unstructured":"Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, et al. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 2006;119:355.e15\u201324.","journal-title":"Am J Med"},{"key":"2375_CR10","first-page":"699","volume":"39","author":"PL Jager","year":"1998","unstructured":"Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value. J Nucl Med 1998;39:699\u2013706.","journal-title":"J Nucl Med"},{"key":"2375_CR11","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.rmed.2005.04.030","volume":"99","author":"GP Currie","year":"2005","unstructured":"Currie GP, Rossiter C, Dempsey OJ, Legge JS. Pulmonary amyloid and PET scanning. Respir Med 2005;99:1463\u20134.","journal-title":"Respir Med"},{"key":"2375_CR12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.rlu.0000162965.38269.3c","volume":"30","author":"A Grubstein","year":"2005","unstructured":"Grubstein A, Shitrit D, Sapir EE, Cohen M, Kramer MR. Pulmonary amyloidosis: detection with PET-CT. Clin Nucl Med 2005;30:420\u20131.","journal-title":"Clin Nucl Med"},{"key":"2375_CR13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/01.rlu.0000099807.66221.64","volume":"28","author":"J Kung","year":"2003","unstructured":"Kung J, Zhuang H, Yu JQ, Duarte PS, Alavi A. Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography. Clin Nucl Med 2003;28:975\u20136.","journal-title":"Clin Nucl Med"},{"key":"2375_CR14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00003072-200410000-00018","volume":"29","author":"GP Ollenberger","year":"2004","unstructured":"Ollenberger GP, Knight S, Tauro AJ. False-positive FDG positron emission tomography in pulmonary amyloidosis. Clin Nucl Med 2004;29:657\u20138.","journal-title":"Clin Nucl Med"},{"key":"2375_CR15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.lungcan.2009.11.014","volume":"67","author":"JH Seo","year":"2010","unstructured":"Seo JH, Lee SW, Ahn BC, Lee J. Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET\/CT. Lung Cancer 2010;67:376\u20139.","journal-title":"Lung Cancer"},{"key":"2375_CR16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/RLU.0b013e318219b16e","volume":"36","author":"M Soussan","year":"2011","unstructured":"Soussan M, Ouvrier MJ, Pop G, Galas JL, Neuman A, Weinmann P. Tracheobronchial FDG uptake in primary amyloidosis detected by PET\/CT. Clin Nucl Med 2011;36:723\u20134.","journal-title":"Clin Nucl Med"},{"key":"2375_CR17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/RLU.0b013e3181cc64b5","volume":"35","author":"H Tan","year":"2010","unstructured":"Tan H, Guan Y, Zhao J, Lin X. Findings of pulmonary amyloidosis on dual phase FDG PET\/CT imaging. Clin Nucl Med 2010;35:206\u20137.","journal-title":"Clin Nucl Med"},{"key":"2375_CR18","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1200\/JCO.2008.18.6338","volume":"26","author":"A Yoshida","year":"2008","unstructured":"Yoshida A, Borkar S, Singh B, Ghossein RA, Sch\u00f6der H. Incidental detection of concurrent extramedullary plasmacytoma and amyloidoma of the nasopharynx on [18F]fluorodeoxyglucose positron emission tomography\/computed tomography. J Clin Oncol 2008;26:5817\u20139.","journal-title":"J Clin Oncol"},{"key":"2375_CR19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/RLU.0b013e318156bb56","volume":"32","author":"I Serizawa","year":"2007","unstructured":"Serizawa I, Inubushi M, Kanegae K, Morita K, Inoue T, Shiga T, et al. Lymphadenopathy due to amyloidosis secondary to Sj\u00f6gren syndrome and systemic lupus erythematosus detected by F-18 FDG PET. Clin Nucl Med 2007;32:881\u20132.","journal-title":"Clin Nucl Med"},{"key":"2375_CR20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3348\/kjr.2011.12.5.634","volume":"12","author":"YM Son","year":"2011","unstructured":"Son YM, Choi JY, Bak CH, Cheon M, Kim YE, Lee KH, et al. 18F-FDG PET\/CT in primary AL hepatic amyloidosis associated with multiple myeloma. Korean J Radiol 2011;12:634\u20137.","journal-title":"Korean J Radiol"},{"key":"2375_CR21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/RLU.0b013e3181feefd4","volume":"36","author":"A Mekinian","year":"2011","unstructured":"Mekinian A, Ghrenassia E, Pop G, Roberts S, Prendki V, Stirnemann J, et al. Visualization of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET\/CT scan. Clin Nucl Med 2011;36:52\u20133.","journal-title":"Clin Nucl Med"},{"key":"2375_CR22","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jbspin.2009.01.015","volume":"76","author":"F Costantino","year":"2009","unstructured":"Costantino F, Loeuille D, Dinfinger H, P\u00e9r\u00e9 P, Chary-Valckenaere I. Fixed digital contractures revealing light-chain amyloidosis. Joint Bone Spine 2009;76:553\u20135.","journal-title":"Joint Bone Spine"},{"key":"2375_CR23","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3748\/wjg.v16.i20.2566","volume":"16","author":"PP Mainenti","year":"2010","unstructured":"Mainenti PP, Segreto S, Mancini M, Rispo A, Cozzolino I, Masone S, et al. Intestinal amyloidosis: two cases with different patterns of clinical and imaging presentation. World J Gastroenterol 2010;16:2566\u201370.","journal-title":"World J Gastroenterol"},{"key":"2375_CR24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/13506129.2012.682833","volume":"19","author":"A Mekinian","year":"2012","unstructured":"Mekinian A, Jaccard A, Soussan M, Launay D, Berthier S, Federici L, et al. 18F-FDG PET\/CT in patients with amyloid light-chain amyloidosis: case-series and literature review. Amyloid 2012;19:94\u20138.","journal-title":"Amyloid"},{"key":"2375_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature09494","volume":"468","author":"K Bodin","year":"2010","unstructured":"Bodin K, Ellmerich S, Kahan MC, Tennent GA, Loesch A, Gilbertson JA, et al. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. Nature 2010;468:93\u20137.","journal-title":"Nature"},{"key":"2375_CR26","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1073\/pnas.92.10.4299","volume":"92","author":"GA Tennent","year":"1995","unstructured":"Tennent GA, Lovat LB, Pepys MB. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A 1995;92:4299\u2013303.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2375_CR27","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nm0897-855","volume":"3","author":"M Botto","year":"1997","unstructured":"Botto M, Hawkins PN, Bickerstaff MC, Herbert J, Bygrave AE, McBride A, et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat Med 1997;3:855\u20139.","journal-title":"Nat Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2375-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-013-2375-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2375-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:05:26Z","timestamp":1558699526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-013-2375-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,9]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["2375"],"URL":"https:\/\/doi.org\/10.1007\/s00259-013-2375-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,9]]}}}